Birmingham-based Lioncroft Wholesale has created a new fellowship to help transform the lives of children with cancer and their families.
Lioncroft Wholesale, which has depots in Aston and Smethwick, created the Lioncroft Foundation to support charitable initiatives locally and around the world.
Founded by CEO Jason Wouhra, wife Daali and family from Lioncroft Wholesale, the Lioncroft Foundation has made a major donation to The Cancer Awareness Trust which has enabled it to appoint a dedicated Childhood Cancer Specialist – Lioncroft Fellow, in collaboration with Solving Kids’ Cancer UK, a leading childhood cancer charity.
The Lioncroft Fellow role, filled by clinical researcher Ali Timmons, will support families whose children have been diagnosed with Neuroblastoma, which is the second most common solid tumour in children after brain tumours and usually affects children under five.
“Sadly, cancer is an illness that affects large numbers of individuals and their families, including our own,” said Jason Wouhra OBE. “Childhood cancer is a heartbreaking condition and we are honoured to have the opportunity through the Lioncroft Foundation to support children who are diagnosed with Neuroblastoma.
“We are hopeful that through our support this condition will be researched further to provide help and guidance to families as well as the development of clinical trials to make enough of a difference to enable the elimination of this condition altogether.
“The Lioncroft Foundation aims to assist those in need, be it regionally, nationally or internationally,” said Jason. “This funding kickstarts the Lioncroft Foundation’s plans to support many more charities in the coming years.”
The Cancer Awareness Trust UK director Kiran Sehmi added: “The development of a specialised childhood cancer navigation pathway, especially targeting Neuroblastoma is an exceptionally fulfilling project for the Cancer Platform. It signifies potential impact on the lives of children and their families facing this particular form of cancer. This innovation represents a significant step forward in improving cancer care.”